Banner of MedPro Systems' offerings

Newsroom


DOJ Introduces New Safe Harbor Policy

DOJ Introduces Safe-Harbor Policy for Disclosing Uncovered Misconduct During Mergers and Acquisitions

If Your Organization May Acquire or Be Acquired by Another Corporate Entity, Be Mindful of the Critical Importance of Corporate Compliance On October 4, 2023, the Department of Justice (“DOJ”), through Deputy Attorney General Lisa Monaco, announced a new safe-harbor policy for voluntary disclosures of corporate misconduct uncovered in connection…

Banner of MedPro Systems' offerings

MedPro Systems Appoints Former Federal Prosecutor & Chief at the U.S. Attorney’s Office Maureen Ruane as Director, Compliance Advisory Services

Strengthening MedPro’s In-House Compliance Expertise for Building, Maintaining and Enhancing Effective Compliance Programs for the Life Sciences Industry That Can Best Withstand and Potentially Avoid Government Scrutiny View the official press release here. MOUNT ARLINGTON, N.J., Sept. 19, 2023 — MedPro Systems, the leading provider of commercial and compliance solutions…

2023 Transparency and Aggregate Spend Conference Insights

2023 Transparency and Aggregate Spend Conference Insights

The MedPro Systems team recently enjoyed attending Informa’s 2023 Transparency, Aggregate Spend & HCP Engagement conference in Washington, D.C. It was an excellent opportunity to connect with so many Life Sciences organizations, teams, and people we support, while keeping current on the newest challenges facing our industry. Access MedPro’s Presentations…

MedPro Systems Launches State Drug Price Reporting Reference Solution

MedPro Systems Launches State Drug Price Reporting Reference Solution

MOUNT ARLINGTON, N.J., Jan. 31, 2023 — MedPro Systems, the leading provider of commercial and compliance solutions for the Life Sciences industry, today launched an expansion to their authoritative transparency reference library solution, RegulatoryID, to cover US state drug price reporting regulations. With this expansion, pharmaceutical manufacturers can view and…

Webinar: Navigate State Drug Price Reporting with Ease

Webinar: Navigate State Drug Price Reporting with Ease

From launching a new product to adjusting existing price structures, it’s critical that pharmaceutical manufacturers are aware of how their pricing decisions can trigger state-level reporting obligations across the US. However, with more than 30 unique reporting requirements already enacted and more pending legislation on the way, it can be…


Archives